skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: The gene business. Who should control biotechnology

Abstract

This book discusses about the big business of genetic engineering. The author argues that the questions raised by biotechnology should be decided on ethical grounds and in terms of the public good; whereas the corporations that have sprung up to manufacture and market these man-made organisms will decide them solely in terms of profit. He examines affected (and threatened) areas such as agriculture (new crops, animal breeding); chemistry (new fuels); and pharmacology (interferon, artificial insulin); naming names and including the corporations, drug companies and scientists engaged in this enterprise, no less revolutionary than nuclear power.

Authors:
Publication Date:
OSTI Identifier:
6044442
Alternate Identifier(s):
OSTI ID: 6044442
Resource Type:
Book
Country of Publication:
United States
Language:
English
Subject:
29 ENERGY PLANNING, POLICY AND ECONOMY; 59 BASIC BIOLOGICAL SCIENCES; 09 BIOMASS FUELS; ANIMAL BREEDING; BIOTECHNOLOGY; BACTERIA; SUPPLY AND DEMAND; COMMERCIALIZATION; COST OVERRUNS; ECONOMIC IMPACT; ETHICAL ASPECTS; MARKETING RESEARCH; CROPS; DRUGS; FUELS; INSULIN; BIOSYNTHESIS; CHEMISTRY; ECONOMICS; GENE AMPLIFICATION; GENE REGULATION; GENES; GENETIC CONTROL; MAN-MACHINE SYSTEMS; MANUFACTURERS; NUCLEAR POWER; PHARMACOLOGY; CONTROL; COST; HORMONES; MICROORGANISMS; PEPTIDE HORMONES; PEST CONTROL; POWER; SYNTHESIS 290200* -- Energy Planning & Policy-- Economics & Sociology; 550400 -- Genetics; 550200 -- Biochemistry; 140504 -- Solar Energy Conversion-- Biomass Production & Conversion-- (-1989); 290500 -- Energy Planning & Policy-- Research, Development, Demonstration, & Commercialization

Citation Formats

Yoxen, E. The gene business. Who should control biotechnology. United States: N. p., 1984. Web.
Yoxen, E. The gene business. Who should control biotechnology. United States.
Yoxen, E. Sun . "The gene business. Who should control biotechnology". United States. doi:.
@article{osti_6044442,
title = {The gene business. Who should control biotechnology},
author = {Yoxen, E.},
abstractNote = {This book discusses about the big business of genetic engineering. The author argues that the questions raised by biotechnology should be decided on ethical grounds and in terms of the public good; whereas the corporations that have sprung up to manufacture and market these man-made organisms will decide them solely in terms of profit. He examines affected (and threatened) areas such as agriculture (new crops, animal breeding); chemistry (new fuels); and pharmacology (interferon, artificial insulin); naming names and including the corporations, drug companies and scientists engaged in this enterprise, no less revolutionary than nuclear power.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {Sun Jan 01 00:00:00 EST 1984},
month = {Sun Jan 01 00:00:00 EST 1984}
}

Book:
Other availability
Please see Document Availability for additional information on obtaining the full-text document. Library patrons may search WorldCat to identify libraries that hold this book.

Save / Share: